Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
Vox Sang ; 100(3): 340-2, 2011 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-21392024

RESUMO

BACKGROUND AND OBJECTIVE: The risk of hepatitis E virus (HEV) to blood safety remains unknown in England. Reports of persistent HEV infection with serious disease sequelae indicate that transfusion transmitted HEV is not a trivial disease in immunosuppressed patients. MATERIALS AND METHODS: Samples from unselected blood donors and donors with a history of jaundice were tested for HEV antibody and RNA. RESULTS: Overall, 10% of the donor sera were anti-HEV IgG reactive. Four of the donor samples were anti-HEV IgM reactive but HEV RNA negative. CONCLUSION: There is evidence of probable recent HEV infections in donors with a predicted attack rate of 2.8%.


Assuntos
Doadores de Sangue , Vírus da Hepatite E/isolamento & purificação , Hepatite E/diagnóstico , Hepatite E/transmissão , Anticorpos Antivirais/sangue , Inglaterra , Humanos , Imunoglobulina G , Imunoglobulina M , Icterícia , RNA Viral/sangue , Reação Transfusional , País de Gales
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...